CD147 reinforces [Ca2+]i oscillations and promotes oncogenic progression in hepatocellular carcinoma.

Juan Tang,Yun-Shan Guo,Xiao-Ling Yu,Wan Huang,Ming Zheng,Ying-Hui Zhou,Gang Nan,Jian-Chao Wang,Hai-Jiao Yang,Jing-Min Yu,Jian-Li Jiang,Zhi-Nan Chen
DOI: https://doi.org/10.18632/oncotarget.5225
2015-01-01
Oncotarget
Abstract:Oscillations in intracellular Ca2+ concentrations ([Ca2+](i)) mediate various cellular function. Although it is known that [Ca2+](i) oscillations are susceptible to dysregulation in tumors, the tumor-specific regulators of [Ca2+](i) oscillations are poorly characterized. We discovered that CD147 promotes hepatocellular carcinoma (HCC) metastasis and proliferation by enhancing the amplitude and frequency of [Ca2+](i) oscillations in HCC cells. CD147 activates two distinct signaling pathways to regulate [Ca2+](i) oscillations. By activating FAK-Src-IP3R1 signaling pathway, CD147 promotes Ca2+ release from endoplasmic reticulum (ER) and enhances the amplitude of [Ca2+](i) oscillations. Furthermore, CD147 accelerates ER Ca2+ refilling and enhances the frequency of [Ca2+](i) oscillations through activating CaMKP-PAK1-PP2A-PLB-SERCA signaling pathway. Besides, CD147-promoted ER Ca2+ release and refilling are tightly regulated by changing [Ca2+](i). CD147 may activate IP3R1 channel under low [Ca2+](i) conditions and CD147 may activate SERCA pump under high [Ca2+](i) conditions. CD147 deletion suppresses HCC tumorigenesis and increases the survival rate of liver-specific CD147 knockout mice by regulating [Ca2+](i) oscillations in vivo. Together, these results reveal that CD147 functions as a critical regulator of ER-dependent [Ca2+](i) oscillations to promote oncogenic progression in HCC.
What problem does this paper attempt to address?